Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Navidea Biopharmaceuticals, Inc. (NAVB)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.7100-0.0100 (-0.58%)
At close: 4:00PM EDT
1.5800 -0.13 (-7.60%)
After hours: 05:19PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/19/2021
Current
6/30/20213/31/202112/31/20209/30/2020
Market Cap (intraday) 5
53.09M55.17M57.99M58.37M71.21M
Enterprise Value 3
46.41M48.36M56.65M55.68M70.71M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
55.3253.6352.7557.4868.42
Price/Book (mrq)
9.3112.9044.08343.61N/A
Enterprise Value/Revenue 3
53.19185.27457.85253.96263.48
Enterprise Value/EBITDA 7
-3.99-18.25-19.23-20.02-24.53

Trading Information

Stock Price History

Beta (5Y Monthly) 1.84
52-Week Change 3-32.14%
S&P500 52-Week Change 333.64%
52 Week High 33.1500
52 Week Low 31.4600
50-Day Moving Average 31.6788
200-Day Moving Average 31.7193

Share Statistics

Avg Vol (3 month) 345.66k
Avg Vol (10 day) 358.31k
Shares Outstanding 530.16M
Implied Shares Outstanding 6N/A
Float 821.74M
% Held by Insiders 127.74%
% Held by Institutions 15.57%
Shares Short (Sep 29, 2021) 4187.15k
Short Ratio (Sep 29, 2021) 43.7
Short % of Float (Sep 29, 2021) 40.95%
Short % of Shares Outstanding (Sep 29, 2021) 40.62%
Shares Short (prior month Aug 30, 2021) 4173.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 25, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 25, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,340.93%

Management Effectiveness

Return on Assets (ttm)-79.53%
Return on Equity (ttm)-275.03%

Income Statement

Revenue (ttm)872.42k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-3.70%
Gross Profit (ttm)913.97k
EBITDA -11.63M
Net Income Avi to Common (ttm)-11.95M
Diluted EPS (ttm)-0.4360
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.11M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)434.32k
Total Debt/Equity (mrq)6.75
Current Ratio (mrq)2.49
Book Value Per Share (mrq)0.19

Cash Flow Statement

Operating Cash Flow (ttm)-10.67M
Levered Free Cash Flow (ttm)-5.3M
Advertisement
Advertisement